Scinai Immunotherapeutics Ltd. Sponsored ADR SCNI 深 滬
已收盤 08-07 16:00:00 美东时间
0.2453
-0.013
-5.22%
華盛通- 最 高0.2599
- 今 開0.25
- 成交量 20.18万股
- 最 低 0.2406
- 昨 收 0.2588
- 總市值 126.80万
- 52周最高 1.79
- 市盈率 靜 --
- 換手率 3.90%
- 52周最低 0.2147
- 委 比 -97.65%
- 總股本 516.94万
- 歷史最高 6200.00
- 量 比 0.16
- 振 幅 7.46%
- 歷史最低 0.2147
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today
Scinai Immunotherapeutics shares are surging Friday after it announced fresh financing tied to a private placement and warrant exercise.
04-24 22:25
Scinai Immunotherapeutics Enters Securities Purchase Agreement For Up To 5.21M ADS And Warrants Priced At $0.48 Per Unit
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI), ("Scinai" or the "Company") a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics and the owner of Scinai Biopharma
04-24 20:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing
Financing led by institutional life sciences investor, with participation from new and existing investors Capital expected to support expansion of CDMO platform and advancement of customer p...
04-24 20:00
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $17 billion. Shares jump 20.2% to $493.01.
04-20 16:37
Scinai Immunotherapeutics shares are trading higher after the company reported a year-over-year increase in FY sales results.
Scinai Immunotherapeutics shares are trading higher after the company reported ...
04-01 23:34
Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY
Scinai Immunotherapeutics (NASDAQ:SCNI) reported quarterly losses of $(3.56) per share. The company reported $1.311 million in sales this quarter. This is a 99.24 percent increase over sales of $658.000 thousand the
04-01 20:09
Scinai Immunotherapeutics Receives Non-Compliance Notification From Nasdaq
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) ("Scinai" or the "Company"), today announced that it received a written notification from the Nasdaq Listing Qualifications Department on March 12, 2026 indicating that
03-17 04:14
Scinai Executes Second Amendment To Binding Option Agreement For Acquisition Of PinCell And Submits Revised Application Under European FENG SMART Path Program
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI);("Scinai" or the "Company"), today announced the execution of a Second Amendment to its Binding Option Agreement for the acquisition of PinCell S.r.l., and the submission
03-02 22:22
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
Scinai Immunotherapeutics ( ($SCNI) ) has issued an announcement. On October 6,...
2025-10-06 20:20
